The American College of Radiology Imaging Network (ACRIN) and the Eastern Cooperative Oncology Group (ECOG) announced that the name of the two organizations combined clinical research alliance will be the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN).  The newly formed entity will conduct research focused on the full cancer care continuum.

Researchers at UCLAs Jonsson Comprehensive Cancer Center have developed a gene-based imaging system to target castration resistant prostate cancers (CRPCs), potentially allowing oncologists to find and treat metastases faster.

Months after Sanofi-Aventis yanked its Phase IIIb PALLAS trial studying dronedarone (Multaq) due to an increase of cardiovascular event rates, the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use has recommended that the drug's use be restricted.

Avoiding unnecessary CT exams, adjusting individual scanning parameters, revising protocols and educating staff were among a number of methods that radiologists at William Beaumont Hospital in Royal Oak, Mich., found effective in reducing CT radiation dose.

The FDA has approved Toshiba America Medical Systems M-Power MR system user interface.

The effective radiation dose for a CT fluoroscopy is about half of conventional fluoroscopy when guiding epidural steroid injections; however, the overall radiation dose is substantially higher when a full lumbar planning CT scan is performed as part of the CT-guided procedure, according to a study published in the October edition of the American Journal of Roentgenology.

Breaking down the burden of heart failure (HF) was all the rage at the 15th annual Heart Failure Society of Americas (HFSA) scientific sessions held this week in Boston. Thought leaders from across the U.S. met to brainstorm on how HF readmission can be prevented and how clinical tools and proteins, like Galectin-3, can better predict HF. While many agreed that HF care has improved, the cost burden from HF readmissions remains a major problem that needs to be improved upon.

Prostate biopsies among Medicare beneficiaries are associated with a significant rise in complications requiring hospitalization, according to a study to published online in the November issue of Journal of Urology.